Group leader / fixed 5-year term (extendable by 4 years) position
Principal Investigator in Genome Editing and Cellular Immunotherapy
Vilnius University Life Sciences Center
- , Add deadline: choose a calendar
- Vilnius, Lithuania
- Genetic Engineering, Immunology and
About
Independent group leader position at the EMBL Partnership Institute for Genome Editing Technologies to establish a research programme at the interface of genome editing and immune-cell-based therapies, including next-generation CAR-T and CAR-NK therapies, in vivo genome editing, engineered immune cell platforms and translational immunotherapy.
Requirements
PhD; early-career researcher up to 8 years after PhD.
Topics
- Genome Editing, search World Wide
- CAR-T, search World Wide
- Cellular Immunotherapy, search World Wide
- immune-cell-based therapies, search World Wide
- CAR-NK therapies, search World Wide
- in vivo genome editing, search World Wide
- engineered immune cell platforms, search World Wide
- translational immunotherapy, search World Wide
Details
Location
Vilnius, Vilnius City Municipality, Lithuania
Source: gmc.vu.lt